BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read Full article: Compounded glucagon like peptide 1 receptor agonists for weight loss: the direct to consumer market in Colorado